SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-24-004635
Filing Date
2024-07-08
Accepted
2024-07-08 16:30:34
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q opgeninc_10q.htm   iXBRL 10-Q 1100516
2 EXHIBIT 31.1 opgeninc_ex31-1.htm EX-31.1 16012
3 EXHIBIT 32.1 opgeninc_ex32-1.htm EX-32.1 7281
  Complete submission text file 0001829126-24-004635.txt   6402185

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE opgn-20240331.xsd EX-101.SCH 55396
5 XBRL CALCULATION FILE opgn-20240331_cal.xml EX-101.CAL 54132
6 XBRL DEFINITION FILE opgn-20240331_def.xml EX-101.DEF 247098
7 XBRL LABEL FILE opgn-20240331_lab.xml EX-101.LAB 363134
8 XBRL PRESENTATION FILE opgn-20240331_pre.xml EX-101.PRE 323074
65 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_10q_htm.xml XML 997020
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37367 | Film No.: 241105089
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)